ACT for the Home Management in Malagasy Children

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the feasibility, the acceptability and the effectiveness of the use of the Artesunate + Amodiaquine Fixed Dose Combination for the home management of presumed malaria in Malagasy children by the community-based service providers.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Malaria Control Programme, Madagascar
• Collaborators: Adventist Development and Relief Agency; Institut Pasteur de Madagascar; Inter Aide Santé,; Population Services International; Reggio Terzo Mondo; SAF FJKM; Sanofi; Santé Net
• Treatments: Amodiaquine; Artemisinins; Artesunate

Criteria

Inclusion Criteria:

• All children under the age of five years (2 months to 5 years) having fever and consulting the community-based service provider, residing in the zone covered by the community-based service provider throughout the entire follow-up period, having signed an informed consent

Exclusion Criteria:

• Children with no informed consent